0

Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement

The complex, costly, and continuously evolving arena of biopharmaceutical product development demands a constant eye on commercialization potential. Continue Reading

Educating the Next Leaders in Applied HEOR: Jefferson’s Unique Approach

In this blog, Dr. Peeples interviews Dr. Vittorio Maio, Jefferson’s AHEOR Program Director and they discuss how his team has devised a curriculum and an online experience that enables working professionals to enhance their career while maintaining their full-time job. Continue Reading

Payer Contact in a “Contactless” World: Achieving Early Engagement

In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform. Continue Reading

Reducing market access risk: how digital technology is strengthening strategies

Developing innovative pharmaceutical products is a lengthy process with no guarantee of success at the end. Manufacturers struggle with coordinating strategy internally and incorporating multiple payer requirements in clinical development programs. In the fourth of her five-part series on digital… Continue Reading